FindTrial
Sign In

Treatment and followup outcomes of gynecological cancer patients treated with radiation therapy during lockdown phase of COVID pandemic

Outcomes of treatment and followup of patients treated with radiation therapy in gynecological cancer during lockdown phase of COVID pandemic

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028571
Enrollment
1500
Registered
2020-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: C51-C58- Malignant neoplasms of female genital organs

Interventions

None listed

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients treated in Gynecology unit of radiation therapy in TMH, referred out, and/or followed up from 01.03.2020 to 31.07.2020 2. All age groups will be included in the study.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Audit of treatment characteristics of patients treated during COVID- 19 lockdown period.Timepoint: 01.03.2020 to 31.07.2020—

Secondary

MeasureTime frame
Acute complications and outcomes of treatment of patients treatedTimepoint: 3 years;Compliance of patientsTimepoint: During COVID- 19 lockdown period.;To report on common patient symptoms during telephonic follow up consultationTimepoint: During COVID- 19 lockdown period.;To report on long term cancer specific outcomes of patients treatedTimepoint: 3 years—

Countries

India

Contacts

Public ContactDr Supriya Chopra

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)

supriyasastri@gmail.com9930958309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026